Submitting a referral to VicSIS has changed

The Victorian Specialist Immunisation Services (VicSIS) network has launched a new eReferral system. This new centralised referral and triaging system will allow for a more timely review of adults and children who have experienced an adverse event following immunisation (AEFI) with a COVID-19 vaccine.

This new referral pathway replaces the previous practice of emailing written referrals through to individual clinics.

For more information and to access the new eReferral system, please click on the link below:
MVEC: Victorian Specialist Immunisation Services (VicSIS) eReferral system


New immunisation reference page: COVID-19 mandatory vaccination directions in Victoria

Due to the potential for high levels of disease transmission and an increased risk of severe disease in vulnerable groups, COVID-19 vaccination has been made mandatory for specific workplaces/industries within Victoria.

Our new reference page outlines the current COVID-19 Mandatory Vaccination Directions Order in place in Victoria, including an overview of the responsibilities for both employers and employees, as well as information regarding the medical exemptions for COVID-19 vaccines.

 

To read more follow the link below:
MVEC: COVID-19 mandatory vaccination directions in Victoria


New immunisation reference page: Neutropenia: Vaccine recommendations for children with chronic neutropenia

Children with neutropenia are at increased risk of bacterial and fungal infections and therefore preventing infections in this group is a priority in order to protect these children against vaccine preventable diseases (VPDs). However, this patient group is not addressed in The Australian Immunisation Handbook.

Our new reference page, Neutropenia: vaccine recommendations for children with chronic neutropenia discusses the recommendations for this group based on international guidelines and local consensus.

To read more follow the link below:
MVEC: New immunisation reference page: Neutropenia: Vaccine recommendations for children with chronic neutropenia


TGA Provisional Approval of Moderna COVID-19 vaccine to include 12-17 years age group

On September 4 2021, the Therapeutic Goods Administration (TGA) granted provisional approval to Moderna Australia Pty Ltd for its COVID-19 vaccine—Spikevax (elasomeran) to include the 12-17 years age group. This decision follows the provisional approval granted by the TGA to Spikevax on 9 August 2021 for use in individuals aged 18 years and older.

To find out more information, please refer to our dedicated MVEC Moderna COVID-19 vaccination page in the link below:

MVEC Moderna COVID-19 vaccination page


New immunisation reference page: Immune thrombocytopenia (ITP)

Immune thrombocytopenia, also previously known as idiopathic thrombocytopenia purpura (ITP), is an uncommon autoimmune condition in which the body’s own immune system attacks platelets (the cells found in the blood which normally help the blood to clot).

Our new reference page discusses the background of ITP, including presentation of the condition and the association between ITP and MMR vaccines. Our page also answers questions around ITP and COVID-19 vaccines, including whether or not COVID-19 vaccines should be administered to people with a history of ITP.

To read more follow the link below:
MVEC: Immune thrombocytopenia (ITP)


MVEC animation: Myocarditis, pericarditis and COVID-19 vaccines

MVEC have created a new animation to help explain myocarditis and pericarditis which have been reported in a small number of individuals who have received mRNA COVID-19 vaccines Comirnaty™ and Moderna.

To view the animation and to find out more information, please refer to our myocarditis, pericarditis following COVID-19 mRNA vaccines immunisation reference page:
MVEC animation: Myocarditis and pericarditis following COVID-19 mRNA vaccines


COVID-19 vaccine FAQs: women's health

We have expanded our COVID-19 vaccine FAQs to include a section specific to women's health.

To view commonly asked questions on COVID vaccines and planning pregnancy, pregnancy, breast-feeding and menstruation please please follow the link below:

MVEC: COVID-19 vaccine FAQs: women's health

 

 


Updated immunisation reference page: Needle phobia

We have recently updated our Needle phobia page to include the latest information and resources available for addressing needle phobia.

Our page includes information and strategies for health care providers, individuals and care givers to manage needle phobia and immunisation.

To view this page, please click on the following link:

MVEC: Needle phobia


SAEFVIC Rapid report: a new reporting pathway for COVID-19 vaccine AEFI

Reporting adverse events following immunisation (AEFI) is not mandatory in Victoria, however doing so allows the rapid investigation of any potential vaccine or system problems. This helps to ensure a safe and effective immunisation program and it maintains community confidence in vaccines.

The new SAEFVIC Rapid reporting pathway has been launched for reporting any common or expected side effects following a COVID-19 vaccine. Reporting via this pathway will not result in follow up of clinical symptoms however it will contribute to data collection and assist health authorities to understand the frequency of symptoms occurring. Should the vaccinee experience significant side effects, completing the SAEFVIC Extended report is recommended.

For more information on SAEFVIC, symptoms that should be reported, and instructions on how to report, please visit our immunisation reference page below:

MVEC: Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC)


Updated immunisation reference page: Vaccine confidence

We have recently updated our Vaccine confidence immunisation reference page to include the latest information  and resources available to help address people’s questions and concerns about vaccines.

Our page includes information on how to talk to people who have concerns about vaccines, how to tackle misinformation and how to be a vaccine champion in your workplace or community.

To view this page, please click on the following link:

MVEC: Vaccine confidence

 


About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.